Show simple item record

dc.contributor.authorRivera, A.
dc.contributor.authorOhri, N.
dc.contributor.authorMiller, R.
dc.date.accessioned2020-04-28T20:12:23Z
dc.date.available2020-04-28T20:12:23Z
dc.date.issued2020
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85083554693&doi=10.1016%2fj.adro.2020.03.006&partnerID=40&md5=3d05b9836e2b793183f46d3ccaac74bf
dc.identifier.urihttp://hdl.handle.net/10713/12672
dc.description.abstracten_US
dc.description.abstractPatients with cancer are known to be at an increased risk for community-acquired respiratory viruses, such as influenza, because of their frequently observed immunocompromised state.5 The spread of SARS-CoV-2 is of particular concern in this vulnerable population, given the higher case fatality rate seen in Wuhan and the potentially increased severity of the disease course with COVID-19.en_US
dc.description.urihttps://doi.org/10.1016/j.adro.2020.03.006en_US
dc.language.isoen_USen_US
dc.publisherElsevier Incen_US
dc.relation.ispartofAdvances in Radiation Oncology
dc.subjectCoronavirus Disease 2019 (COVID-19)en_US
dc.subjectSARS-CoV-2,en_US
dc.subjecthigh risken_US
dc.subject.lcshCanceren_US
dc.subject.meshRadiation Oncologyen_US
dc.titleThe Impact of COVID-19 on Radiation Oncology Clinics and Patients With Cancer in the United Statesen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.adro.2020.03.006


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record